BeStock  
Stocks › Biotechnology › LBRX

LB Pharmaceuticals LBRX

US equityMarket cap rank #3009Biotechnology
$38.85 −$1.19 (-2.97%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $38.85 0.00%
Open$39.53
Prev close$40.04
Day range$38.57 – $40.67
Volume303.1K
Market cap$1.26B
P/E (TTM)38.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings42.4x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -1,614.3x

#2468 of 2991 stocks by PE (1 = cheapest)

Price / book3.3x
CheapRich

Above its usual level · 78th percentile, 5-year average 1.8x

#3905 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-34,702x-20,580x-6,458x7,664xSep '25Apr '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$40.65
Price vs. fair value-4.4%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.33 – 1.84 78% (pricier than usual) #3905 of 5329 (1 = cheapest)
PE 42.42 -6.08 -1,614.28 99% (pricier than usual) #2468 of 2991 (1 = cheapest)
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on LBRX.

Sign in to join the discussion.

Scroll to Top